These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 713439)

  • 1. Plasminogen activator release with experimental vasoconstrictions in the isolated perfused dog leg.
    Izaki S
    Kobe J Med Sci; 1978 Mar; 24(1):1-16. PubMed ID: 713439
    [No Abstract]   [Full Text] [Related]  

  • 2. A further study on plasminogen activator release by vasoactive agents in the isolated perfused dog leg.
    Hirata M; Kitaguchi H; Funahara Y
    Kobe J Med Sci; 1980 Jun; 26(2):101-8. PubMed ID: 7190627
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of thrombin on plasminogen activator release from isolated perfused dog leg.
    Kitaguchi H; Hijikata A; Hirata M
    Thromb Res; 1979; 16(3-4):407-20. PubMed ID: 516002
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg.
    Hijikata-Okunomiya A; Kitaguchi H; Hirata M
    Thromb Res; 1987 Mar; 45(5):699-702. PubMed ID: 3590096
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium dependent and independent release of plasminogen activator from the vascular wall.
    Izaki S; Kitaguchi H
    Thromb Res; 1977 May; 10(5):765-70. PubMed ID: 882962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative characteristics of constrictor effects of physiologically active substances on the internal carotid artery].
    Mchedlishvili GI; Ormotsadze LG
    Patol Fiziol Eksp Ter; 1978; (2):36-40. PubMed ID: 673476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Analysis of plasminogen activator release mechanism in the isolated and perfused hind leg of a dog as a model].
    Izaki S; Kitaguchi H; Ishii M
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):367. PubMed ID: 4478526
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of proteases on plasminogen activator release from isolated perfused dog leg.
    Hijikata A; Hirata M; Kitaguchi H
    Thromb Res; 1980 Dec 1-15; 20(5-6):521-31. PubMed ID: 7015552
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasminogen activator content in heart tissue and perfusate under various experimental conditions.
    Lyutova LV; Andreenko GV; Perova EV; Malchikova LS
    Cor Vasa; 1983; 25(3):206-12. PubMed ID: 6684535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute smoke inhalation on angiotensin converting enzyme, plasminogen activator, and angiotensin-II in the dog.
    Clark WR; Molteni A; Nieman G; Brizio-Molteni L; Solliday NH
    Ann Clin Lab Sci; 1989; 19(6):452-60. PubMed ID: 2557791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular responses to norepinephrine, angiotensin, vasopressin and serotonin.
    Abboud FM
    Fed Proc; 1968; 27(6):1391-5. PubMed ID: 4302173
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluidity of cadaveric blood after sudden death: Part II. Mechanism of release of plasminogen activator from blood vessels.
    Takeichi S; Wakasugi C; Shikata I
    Am J Forensic Med Pathol; 1985 Mar; 6(1):25-9. PubMed ID: 4039106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor subtypes involved in the modulation of purinergic and adrenergic vasoconstrictions to periarterial electrical nerve stimulation in the canine splenic artery.
    Yang XP; Chiba S
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S49-52. PubMed ID: 12688396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of constriction produced by vasoactive agents.
    Grega GJ; Adamski SW
    Fed Proc; 1987 Feb; 46(2):270-5. PubMed ID: 3803618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent vasoconstriction by tyramine but no significant constriction by nicotine in isolated dog ear arteries.
    Chiba S; Tsukada M
    Tohoku J Exp Med; 1991 Nov; 165(3):239-41. PubMed ID: 1807012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute release of plasminogen activator by ethyl alcohol in the isolated perfused pig ear.
    Klöcking HP; Hoffmann A; Sonntag G
    Pharmazie; 1990 May; 45(5):378-9. PubMed ID: 2395906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of mediators on plasminogen activator release].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1978; 37(10):1603-10. PubMed ID: 752212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.